Reconciling Conflicting Evidence on Peri–Immune Checkpoint Inhibitor COVID-19 mRNA Vaccination in Lung Cancer: A Time-Aligned Target Trial Emulation–Informed Landmark Study
Reconciling Conflicting Evidence on Peri–Immune Checkpoint Inhibitor COVID-19 mRNA Vaccination in Lung Cancer: A Time-Aligned Target Trial Emulation–Informed Landmark Study. // Value in Health. – URL: https://www.sciencedirect.com/science/article/pii/S109830152605789X?dgcid=rss_sd_all
Reconciling Conflicting Evidence on Peri–Immune Checkpoint Inhibitor COVID-19 mRNA Vaccination in Lung Cancer: A Time-Aligned Target Trial Emulation–Informed Landmark Study. Value in Health. https://www.sciencedirect.com/science/article/pii/S109830152605789X?dgcid=rss_sd_all
“Reconciling Conflicting Evidence on Peri–Immune Checkpoint Inhibitor COVID-19 mRNA Vaccination in Lung Cancer: A Time-Aligned Target Trial Emulation–Informed Landmark Study.” Value in Health.
@article{article71132,
title = {Reconciling Conflicting Evidence on Peri–Immune Checkpoint Inhibitor COVID-19 mRNA Vaccination in Lung Cancer: A Time-Aligned Target Trial Emulation–Informed Landmark Study},
journal = {Value in Health},
url = {https://www.sciencedirect.com/science/article/pii/S109830152605789X?dgcid=rss_sd_all}
}
Abstract Aim Discretionary foods and beverages contribute to poor diet quality and chronic disease. In Australia, intake exceeds dietary guideline recommendations and is unlikely to improve without substantial intervention. We examined...
ABSTRACT Background Ultra‐processed foods (UPFs) are a leading contributor to diet‐related chronic disease and socio‐ecological harm. Despite increasing recognition of these impacts, regulatory responses remain fragmented, focused on...